Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,064 | -13,413 | -2,055 | -22,721 | -16,093 |
| Depreciation Amortization | 34 | 22 | 10 | 35 | 27 |
| Other Working Capital | 5,000 | 2,742 | -674 | -1,605 | -2,121 |
| Other Operating Activity | 1,960 | 1,219 | 581 | -472 | -1,010 |
| Operating Cash Flow | $-22,070 | $-9,430 | $-2,138 | $-24,763 | $-19,197 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,403 | -24,294 | N/A | 4,212 | 4,212 |
| PPE Investments | -49 | -45 | -45 | -24 | -19 |
| Sale Of Investment | 24,403 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-49 | $-24,339 | $-45 | $4,188 | $4,193 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 80,820 | 80,611 | 80,486 | N/A | 0 |
| Other Financing Activity | -5,640 | -5,640 | -5,637 | 0 | 0 |
| Financing Cash Flow | $75,180 | $74,971 | $74,849 | $N/A | $0 |
| Beginning Cash Position | 14,677 | 14,677 | 14,677 | 35,252 | 35,252 |
| End Cash Position | 67,738 | 55,879 | 87,343 | 14,677 | 20,248 |
| Net Cash Flow | $53,061 | $41,202 | $72,666 | $-20,575 | $-15,004 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,070 | -9,430 | -2,138 | -24,763 | -19,197 |
| Capital Expenditure | -49 | -45 | -45 | -24 | -19 |
| Free Cash Flow | -22,119 | -9,475 | -2,183 | -24,787 | -19,216 |